To demonstrate the predictive power of SLIdR, we sought to validate two of our top hits in HCC, namely ARID1A-TEAD1 and AXIN1-URI1 (Fig. 4a and Supplementary Fig. 5a). This evidence concerns the gene ARID1A and hepatocellular carcinoma.